SEARCH

SEARCH BY CITATION

References

  • Arluison M., Vankova M., Cesselin F. and Leviel V. (1990) Origin of some enkephalin-containing afferents to the ventro-medial region of the globus pallidus in the rat. Brain Res. Bull. 25, 2534.
  • Bachtell R. K., Wang Y. M., Freeman P., Risinger F. O. and Ryabinin A. E. (1999) Alcohol drinking produces brain region-selective changes in expression of inducible transcription factors. Brain Res. 847, 157165.
  • Bachtell R. K., Tsivkovskaia N. O. and Ryabinin A. E. (2002a) Alcohol-induced c-Fos expression in the Edinger-Westphal nucleus: pharmacological and signal transduction mechanisms. J. Pharmacol. Exp. Ther. 302, 516524.
  • Bachtell R. K., Tsivkovskaia N. O. and Ryabinin A. E. (2002b) Strain differences in urocortin expression in the Edinger-Westphal nucleus and its relation to alcohol-induced hypothermia. Neuroscience 113, 421434.
  • Bachtell R. K., Weitemier A. Z., Galvan-Rosas A., Tsivkovskaia N. O., Risinger F. O., Phillips T. J., Grahame N. J. and Ryabinin A. E. (2003) The Edinger-Westphal-lateral septum urocortin pathway and its relationship to alcohol consumption. J. Neurosci. 23, 24772487.
  • Badia-Elder N. E., Stewart R. B., Powrozek T. A., Roy K. F., Murphy J. M. and Li T. K. (2001) Effect of neuropeptide Y (NPY) on oral ethanol intake in Wistar, alcohol-preferring (P), and – nonpreferring (NP) rats. Alcohol. Clin. Exp. Res. 25, 386390.
  • Belknap J. K., Crabbe J. C. and Young E. R. (1993) Voluntary consumption of ethanol in 15 inbred mouse strains. Psychopharmacology (Berl) 112, 503510.
  • Bittencourt J. C., Vaughan J., Arias C., Rissman R. A., Vale W. W. and Sawchenko P. E. (1999) Urocortin expression in rat brain: evidence against a pervasive relationship of urocortin-containing projections with targets bearing type 2 CRF receptors. J. Comp. Neurol. 415, 285312.
  • Brown S. A., Vik P. W., Patterson T. L., Grant I. and Schuckit M. A. (1995) Stress, vulnerability and adult alcohol relapse. J. Stud. Alcohol 56, 538545.
  • Caberlotto L., Thorsell A., Rimondini R., Sommer W., Hyytia P. and Heilig M. (2001) Differential expression of NPY and its receptors in alcohol-preferring AA and alcohol-avoiding ANA rats. Alcohol. Clin. Exp. Res. 25, 15641569.
  • Cassell M. D., Gray T. S. and Kiss J. Z. (1986) Neuronal architecture in the rat central nucleus of the amygdala: a cytological, hodological, and immunocytochemical study. J. Comp. Neurol. 246, 478499.
  • Chang S. L., Patel N. A. and Romero A. A. (1995) Activation and desensitization of Fos immunoreactivity in the rat brain following ethanol administration. Brain Res. 679, 8998.
  • Ciccocioppo R., Panocka I., Pompei P., Polidori C., De Caro G. and Massi M. (1995) Subcutaneous injections of the tachykinin senktide reduce alcohol intake in alcohol-preferring rats. Peptides 16, 533537.
  • Ciccocioppo R., Panocka I., Polidori C., Froldi R., Angeletti S. and Massi M. (1998) Mechanism of action for reduction of ethanol intake in rats by the tachykinin NK-3 receptor agonist aminosenktide. Pharmacol. Biochem. Behav. 61, 459464.
  • Ciccocioppo R., Polidori C., Antonelli L., Salvadori S., Guerrini R. and Massi M. (2002) Pharmacological characterization of the nociceptin receptor which mediates reduction of alcohol drinking in rats. Peptides 23, 117125.
  • Cowen M. S. and Lawrence A. J. (1999) The role of opioid–dopamine interactions in the induction and maintenance of ethanol consumption. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 23, 11711212.
  • Cowen M. S. and Lawrence A. J. (2001) Alterations in central preproenkephalin mRNA expression after chronic free-choice ethanol consumption by fawn-hooded rats. Alcohol. Clin. Exp. Res. 25, 11261133.
  • Cowen M. S., Schumann G., Yagi T. and Spanagel R. (2003) Role of Fyn tyrosine kinase in ethanol consumption in mice. Alcohol. Clin. Exp. Res. 27, 12131219.
  • Crabbe J. C., Kosobud A., Tam B. R., Young E. R. and Deutsch C. M. (1987) Genetic selection of mouse lines sensitive (COLD) and resistant (HOT) to acute ethanol hypothermia. Alcohol Drug Res. 7, 163174.
  • Criado J. R. and Morales M. (2000) Acute ethanol induction of c-Fos immunoreactivity in pre-pro-enkephalin expressing neurons of the central nucleus of the amygdala. Brain Res. 861, 173177.
  • Cunningham C. L., Hallett C. L., Niehus D. R., Hunter J. S., Nouth L. and Risinger F. O. (1991) Assessment of ethanol's hedonic effects in mice selectively bred for sensitivity to ethanol-induced hypothermia. Psychopharmacology (Berl) 105, 8492.
  • Davis M., Hitchcock J. M., Bowers M. B., Berridge C. W., Melia K. R. and Roth R. H. (1994) Stress-induced activation of prefrontal cortex dopamine turnover: blockade by lesions of the amygdala. Brain Res. 664, 207210.
  • Eaton M. J., Wagner C. K., Moore K. E. and Lookingland K. J. (1994) Neurochemical identification of A13 dopaminergic neuronal projections from the medial zona incerta to the horizontal limb of the diagonal band of Broca and the central nucleus of the amygdala. Brain Res. 659, 201207.
  • Erwin V. G., Gehle V. M., Davidson K. and Radcliffe R. A. (2001) Confirmation of correlations and common quantitative trait loci between neurotensin receptor density and hypnotic sensitivity to ethanol. Alcohol. Clin. Exp. Res. 25, 16991707.
  • Fallon J. H. and Leslie F. M. (1986) Distribution of dynorphin and enkephalin peptides in the rat brain. J. Comp. Neurol. 249, 293336.
  • Fallon J. H. and Moore R. Y. (1978) Catecholamine innervation of the basal forebrain. IV. Topography of the dopamine projection to the basal forebrain and neostriatum. J. Comp. Neurol. 180, 545580.
  • Fellmann D., Bugnon C. and Gouget A. (1982) Immunocytochemical demonstration of corticoliberin-like immunoreactivity (CLI) in neurones of the rat amygdala central nucleus (ACN). Neurosci. Lett. 34, 253258.
  • Finley J. C., Lindstrom P. and Petrusz. P. (1981) Immunocytochemical localization of beta-endorphin-containing neurons in the rat brain. Neuroendocrinology 33, 2842.
  • Fire A., Xu S., Montgomery M. K., Kostas S. A., Driver S. E. and Mello C. C. (1998) Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391, 806811.
  • Gianoulakis C., Beliveau D., Angelogianni P., Meaney M., Thavundayil J., Tawar V. and Dumas M. (1989) Different pituitary beta-endorphin and adrenal cortisol response to ethanol in individuals with high and low risk for future development of alcoholism. Life Sci. 45, 10971109.
  • Gianoulakis C., Krishnan B. and Thavundayil J. (1996) Enhanced sensitivity of pituitary beta-endorphin to ethanol in subjects at high risk of alcoholism. Arch. General Psychiatry 53, 250257.
  • Graham R., Wodak A. D. and Whelan G. (2002) New pharmacotherapies for alcohol dependence. Med. J. Aust. 177, 103107.
  • Grahame N. J., Low M. J. and Cunningham C. L. (1998) Intravenous self-administration of ethanol in beta-endorphin-deficient mice. Alcohol. Clin. Exp. Res. 22, 10931098.
  • Grahame N. J., Li T. K. and Lumeng L. (1999) Selective breeding for high and low alcohol preference in mice. Behav. Genet 29, 4757.
  • Grahame N. J., Mosemiller A. K., Low M. J. and Froehlich J. C. (2000) Naltrexone and alcohol drinking in mice lacking beta-endorphin by site-directed mutagenesis. Pharmacol. Biochem. Behav. 67, 759766.
  • Gray T. S. and Magnuson D. J. (1992) Peptide immunoreactive neurons in the amygdala and the bed nucleus of the stria terminalis project to the midbrain central gray in the rat. Peptides 13, 451460.
  • Gray T. S., Cassell M. D. and Kiss J. Z. (1984) Distribution of pro-opiomelanocortin-derived peptides and enkephalins in the rat central nucleus of the amygdala. Brain Res. 306, 354358.
  • Gray T. S., Carney M. E. and Magnuson D. J. (1989) Direct projections from the central amygdaloid nucleus to the hypothalamic paraventricular nucleus: possible role in stress-induced adrenocorticotropin release. Neuroendocrinology 50, 433446.
  • Grisel J. E., Mogil J. S., Grahame N. J., Rubinstein M., Belknap J. K., Crabbe J. C. and Low M. J. (1999) Ethanol oral self-administration is increased in mutant mice with decreased beta-endorphin expression. Brain Res. 835, 6267.
  • Heilig M. (1995) Antisense inhibition of neuropeptide Y (NPY)-Y1 receptor expression blocks the anxiolytic-like action of NPY in amygdala and paradoxically increases feeding. Regul. Pept. 59, 201205.
  • Heilig M. and Thorsell A. (2002) Brain neuropeptide Y (NPY) in stress and alcohol dependence. Rev. Neurosci. 13, 8594.
  • Heinala P., Alho H., Kiianmaa K., Lonnqvist J., Kuoppasalmi K. and Sinclair J. D. (2001) Targeted use of naltrexone without prior detoxification in the treatment of alcohol dependence: a factorial double-blind, placebo-controlled trial. J. Clin. Psychopharmacol. 21, 287292.
  • Hershon H. I. (1977) Alcohol withdrawal symptoms and drinking behavior. J. Stud. Alcohol 38, 953971.
  • Heyser C. J., Roberts A. J., Schulteis G. and Koob G. F. (1999) Central administration of an opiate antagonist decreases oral ethanol self-administration in rats. Alcohol. Clin. Exp. Res. 23, 14681476.
  • Hwang B. H., Zhang J. K., Ehlers C. L., Lumeng L. and Li T. K. (1999) Innate differences of neuropeptide Y (NPY) in hypothalamic nuclei and central nucleus of the amygdala between selectively bred rats with high and low alcohol preference. Alcohol. Clin. Exp. Res. 23, 10231030.
  • Hyytiä P. and Koob G. F. (1995) GABAA receptor antagonism in the extended amygdala decreases ethanol self-administration in rats. Eur. J. Pharmacol. 283, 151159.
  • Inoue K., Valdez. G. R., Reyes T. M., Reinhardt L. E., Tabarin A., Rivier J., Vale W. W., Sawchenko P. E., Koob G. F. and Zorrilla E. P. (2003) Human urocortin II, a selective agonist for the type 2 corticotropin-releasing factor receptor, decreases feeding and drinking in the Rat. J. Pharmacol. Exp. Ther. 305, 385393.
  • Jackson R. V., DeCherney G. S., DeBold C. R., Sheldon W. R., Alexander A. N., Rivier J., Vale W. and Orth D. N. (1984) Synthetic ovine corticotropin-releasing hormone: simultaneous release of proopiolipomelanocortin peptides in man. J. Clin. Endocrinol. Metab. 58, 740743.
  • Koenig H. N. and Olive M. F. (2002) Ethanol consumption patterns and conditioned place preference in mice lacking preproenkephalin. Neurosci. Lett. 325, 7578.
  • Koob G. F. (1992) Drugs of abuse: anatomy, pharmacology and function of reward pathways. Trends Pharmacol. Sci. 13, 177184.
  • Koob G. F., Roberts A. J., Schulteis G., Parsons L. H., Heyser C. J., Hyytia P., Merlo-Pich E. and Weiss F. (1998) Neurocircuitry targets in ethanol reward and dependence. Alcohol. Clin. Exp. Res. 22, 39.
  • Lawrence A. J., Krstew E. V., Dautzenburg F. M. and Rühmann A. (2002) The highly selective CRF2 receptor antagonist K41498 binds to presynaptic CRF2 receptors in rat brain. Br. J. Pharmacol. 136, 896904.
  • Le A. D., Harding S., Juzytsch W., Fletcher P. J. and Shaham Y. (2002) The role of corticotropin-releasing factor in the median raphe nucleus in relapse to alcohol. J. Neurosci. 22, 78447849.
  • Le A. D., Harding S., Juzytsch W., Watchus J., Shalev U. and Shaham Y. (2000) The role of corticotrophin-releasing factor in stress-induced relapse to alcohol-seeking behavior in rats. Psychopharmacology (Berl) 150, 317324.
  • Lewis K., Li C., Perrin M. H. et al (2001) Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor. Proc. Natl. Acad. Sci. USA 98, 75707575.
  • Liu X. and Weiss F. (2002) Additive effect of stress and drug cues on reinstatement of ethanol seeking: exacerbation by history of dependence and role of concurrent activation of corticotropin-releasing factor and opioid mechanisms. J. Neurosci. 22, 78567861.
  • Lodge D. J. and Lawrence A. J. (2001) Comparative analysis of the central CCK system in Fawn Hooded and Wistar Kyoto rats: extended localisation of CCK-A receptors throughout the rat brain using a novel radioligand. Regul. Pept. 99, 191201.
  • Lodge D. J. and Lawrence A. J. (2003) The CRF1 receptor antagonist antalarmin reduces volitional ethanol consumption in isolation-reared fawn-hooded rats. Neuroscience 117, 243247.
  • Loughlin S. E. and Fallon J. H. (1983) Dopaminergic and non-dopaminergic projections to amygdala from substantia nigra and ventral tegmental area. Brain Res. 262, 334338.
  • Maeda H. and Mogenson G. J. (1981) Electrophysiological responses of neurons of the ventral tegmental area to electrical stimulation of amygdala and lateral septum. Neuroscience 6, 367376.
  • Makino S., Shibasaki T., Yamauchi N., Nishioka T., Mimoto T., Wakabayashi I., Gold P. W. and Hashimoto K. (1999) Psychological stress increased corticotropin-releasing hormone mRNA and content in the central nucleus of the amygdala but not in the hypothalamic paraventricular nucleus in the rat. Brain Res. 850, 136143.
  • Marinelli P. W., Quirion R. and Gianoulakis C. (2003) A microdialysis profile of beta-endorphin and catecholamines in the rat nucleus accumbens following alcohol administration. Psychopharmacology (Berl) in press:.
  • Marlatt G. A. and Gordon J. R. (1980) Determinants of relapse: implications for the maintenance of behavior change. In: Behavioral Medicine: Changing Health Lifestyles (Davidson, P. O. and Davidson, S. M., eds), pp. 410452. Brunner/Mazel, New York.
  • McBride W. J. (2002) Central nucleus of the amygdala and the effects of alcohol and alcohol- drinking behavior in rodents. Pharmacol. Biochem. Behav. 71, 509515.
  • Merlo Pich E., Lorang M., Yeganeh M., Rodriguez. de Fonseca F., Raber J., Koob G. F. and Weiss F. (1995) Increase of extracellular corticotropin-releasing factor-like immunoreactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis. J. Neurosci. 15, 54395447.
  • Moller C., Wiklund L., Sommer W., Thorsell A. and Heilig M. (1997) Decreased experimental anxiety and voluntary ethanol consumption in rats following central but not basolateral amygdala lesions. Brain Res. 760, 94101.
  • National Institute on Alcohol Abuse and Alcoholism (2001) Alcoholism: Getting the facts. [www document]. URL http://www.niaaa.nih.gov/publications/booklet.htm [accessed 7 Feb 2003]
  • Naveilhan P., Hassani H., Canals J. M. et al (1999) Normal feeding behavior, body weight and leptin response require the neuropeptide Y Y2 receptor. Nat. Med. 5, 11881193.
  • O'Malley S. S., Jaffe A. J., Chang G., Rode S., Schottenfeld R., Meyer R. E. and Rounsaville B. (1996a) Six-month follow-up of naltrexone and psychotherapy for alcohol dependence. Arch. General Psychiatry 53, 217224.
  • O'Malley S. S., Jaffe A. J., Chang G., Schottenfeld R. S., Meyer R. E. and Rounsaville B. (1992) Naltrexone and coping skills therapy for alcohol dependence. A controlled study. Arch. General Psychiatry 49, 881887.
  • O'Malley S. S., Jaffe A. J., Rode S. and Rounsaville B. J. (1996b) Experience of a ‘slip’ among alcoholics treated with naltrexone or placebo. Am. J. Psychiatry 153, 281283.
  • O'Malley S. S., Krishnan-Sarin S., Farren C., Sinha R. and Kreek J. (2002) Naltrexone decreases craving and alcohol self-administration in alcohol- dependent subjects and activates the hypothalamo-pituitary- adrenocortical axis. Psychopharmacology (Berl) 160, 1929.
  • Ogilvie K. M., Lee S. and Rivier C. (1997) Role of arginine vasopressin and corticotropin-releasing factor in mediating alcohol-induced adrenocorticotropin and vasopressin secretion in male rats bearing lesions of the paraventricular nuclei. Brain Res. 744, 8395.
  • Olive M. F., Koenig H. N., Nannini M. A. and Hodge C. W. (2001) Stimulation of endorphin neurotransmission in the nucleus accumbens by ethanol, cocaine, and amphetamine. J. Neurosci. 21, RC184.
  • Olive M. F., Mehmert K. K., Koenig H. N., Camarini R., Kim J. A., Nannini M. A., Ou C. J. and Hodge C. W. (2003) A role for corticotropin releasing factor (CRF) in ethanol consumption, sensitivity, and reward as revealed by CRF-deficient mice. Psychopharmacology (Berl) 165, 181187.
  • Pandey S. C., Carr L. G., Heilig M. and Ilveskoski and Thiele T. E. (2003a) Neuropeptide Y and alcoholism: genetic, molecular, and pharmacological evidence. Alcohol. Clin. Exp. Res. 27, 149154.
  • Pandey S. C., Roy A. and Zhang H. (2003b) The decreased phosphorylation of cyclic adenosine monophosphate (cAMP) response element binding (CREB) protein in the central amygdala acts as a molecular substrate for anxiety related to ethanol withdrawal in rats. Alcohol. Clin. Exp. Res. 27, 396409.
  • Pettinati H. M. (2001) The use of selective serotonin reuptake inhibitors in treating alcoholic subtypes. J. Clin. Psychiatry 62, 2631.
  • Rassnick S., Heinrichs S. C., Britton K. T. and Koob G. F. (1993) Microinjection of a corticotropin-releasing factor antagonist into the central nucleus of the amygdala reverses anxiogenic-like effects of ethanol withdrawal. Brain Res. 605, 2532.
  • Reyes T. M., Lewis K., Perrin M. H. et al . (2001) Urocortin II: a member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors. Proc. Natl Acad. Sci. USA 98, 28432848.
  • Rezvani A. H., Overstreet D. H., Mason G. A., Janowsky D. S., Hamedi M., Clark E. Jr and Yang Y. (2000) Combination pharmacotherapy: a mixture of small doses of naltrexone, fluoxetine, and a thyrotropin-releasing hormone analogue reduces alcohol intake in three strains of alcohol-preferring rats. Alcohol Alcohol. 35, 7683.
  • Richter R. M., Zorrilla E. P., Basso A. M., Koob G. F. and Weiss F. (2000) Altered amygdalar CRF release and increased anxiety-like behavior in Sardinian alcohol-preferring rats: a microdialysis and behavioral study. Alcohol. Clin. Exp. Res. 24, 17651772.
  • Rivier C., Brownstein M., Spiess J., Rivier J. and Vale W. (1982) In vivo corticotropin-releasing factor-induced secretion of adrenocorticotropin, beta-endorphin, and corticosterone. Endocrinology 110, 272278.
  • Rivier C., Bruhn T. and Vale W. (1984) Effect of ethanol on the hypothalamic-pituitary-adrenal axis in the rat: role of corticotropin-releasing factor (CRF). J. Pharmacol. Exp. Ther. 229, 127131.
  • Roberts A. J., Cole M. and Koob G. F. (1996) Intra-amygdala muscimol decreases operant ethanol self-administration in dependent rats. Alcohol. Clin. Exp. Res. 20, 12891298.
  • Roberts A. J., Gold L. H., Polis I., McDonald J. S., Filliol D., Kieffer B. L. and Koob G. F. (2001) Increased ethanol self-administration in delta-opioid receptor knockout mice. Alcohol. Clin. Exp. Res. 25, 12491256.
  • Roberts A. J., Heyser C. J., Cole M., Griffin P. and Koob G. F. (2000a) Excessive ethanol drinking following a history of dependence: animal model of allostasis. Neuropsychopharmacology 22, 581594.
  • Roberts A. J., McDonald J. S., Heyser C. J., Kieffer B. L., Matthes H. W., Koob G. F. and Gold L. H. (2000b) µ-Opioid receptor knockout mice do not self-administer alcohol. J. Pharmacol. Exp. Ther. 293, 10021008.
  • Ryabinin A. E., Criado J. R., Henriksen S. J., Bloom F. E. and Wilson M. C. (1997) Differential sensitivity of c-Fos expression in hippocampus and other brain regions to moderate and low doses of alcohol. Mol. Psychiatry 2, 3243.
  • Ryabinin A. E., Bachtell R. K., Freeman P. and Risinger F. O. (2001) ITF expression in mouse brain during acquisition of alcohol self-administration. Brain Res. 890, 192195.
  • Ryabinin A. E., Galvan-Rosas A., Bachtell R. K. and Risinger F. O. (2003) High alcohol/sucrose consumption during dark circadian phase in C57BL/6J mice: involvement of hippocampus, lateral septum and urocortin-positive cells of the Edinger-Westphal nucleus. Psychopharmacology (Berl) 165, 296305.
  • Sakanaka M., Shibasaki T. and Lederis K. (1986) Distribution and efferent projections of corticotropin-releasing factor- like immunoreactivity in the rat amygdaloid complex. Brain Res. 382, 213238.
  • Sakanaka M., Shibasaki T. and Lederis K. (1987) Corticotropin releasing factor-like immunoreactivity in the rat brain as revealed by a modified cobalt-glucose oxidase-diaminobenzidine method. J. Comp. Neurol. 260, 256298.
  • Sillaber I., Rammes G., Zimmermann S., Mahal B., Zieglgansberger W., Wurst W., Holsboer F. and Spanagel R. (2002) Enhanced and delayed stress-induced alcohol drinking in mice lacking functional CRH1 receptors. Science 296, 931933.
  • Sinclair J. D. (1998) New treatment options for substance abuse from a public health viewpoint. Ann. Med. 30, 406411.
  • Slawecki C. J., Betancourt M., Walpole T. and Ehlers C. L. (2000) Increases in sucrose consumption, but not ethanol consumption, following ICV NPY administration. Pharmacol. Biochem. Behav. 66, 591594.
  • Slawecki C. J., Jimenez-Vasquez. P., Mathe A. A. and Ehlers C. L. (2001) Substance P and neurokinin levels are decreased in the cortex and hypothalamus of alcohol-preferring (P) rats. J. Stud. Alcohol 62, 736740.
  • Srisurapanont M. and Jarusuraisin N. (2003) Opioid antagonists for alcohol dependence (Cochrane Review). In: The Cochrane Library, Volume Issue, 1. Update Software, Oxford.
  • Sun N. and Cassell M. D. (1993) Intrinsic GABAergic neurons in the rat central extended amygdala. J. Comp. Neurol. 330, 381404.
  • Sun N., Yi H. and Cassell M. D. (1994) Evidence for a GABAergic interface between cortical afferents and brainstem projection neurons in the rat central extended amygdala. J. Comp. Neurol. 340, 4364.
  • Sur C., Wafford K. A., Reynolds D. S. et al (2001) Loss of the major GABAA receptor subtype in the brain is not lethal in mice. J. Neurosci. 21, 34093418.
  • Thiele T. E., Marsh D. J., Ste Marie L., Bernstein I. L. and Palmiter R. D. (1998) Ethanol consumption and resistance are inversely related to neuropeptide Y levels. Nature 396, 366369.
  • Thiele T. E., Miura G. I., Marsh D. J., Bernstein I. L. and Palmiter R. D. (2000) Neurobiological responses to ethanol in mutant mice lacking neuropeptide Y or the Y5 receptor. Pharmacol. Biochem. Behav. 67, 683691.
  • Thiele T. E., Koh M. T. and Pedrazzini T. (2002) Voluntary alcohol consumption is controlled via the neuropeptide Y Y1 receptor. J. Neurosci. 22, RC208.
  • Thorsell A., Rimondini R. and Heilig M. (2002) Blockade of central neuropeptide Y (NPY) Y2 receptors reduces ethanol self-administration in rats. Neurosci. Lett. 332, 14.
  • Timpl P., Spanagel R., Sillaber I., Kresse A., Reul J. M., Stalla G. K., Blanquet V., Steckler T., Holsboer F. and Wurst W. (1998) Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1. Nat. Genet. 19, 162166.
  • Topple A. N., Hunt G. E. and McGregor I. S. (1998) Possible neural substrates of beer-craving in rats. Neurosci. Lett. 252, 99102.
  • Tsai G. and Coyle J. T. (1998) The role of glutamatergic neurotransmission in the pathophysiology of alcoholism. Annu. Rev. Med. 49, 173184.
  • Uhl G. R., Goodman R. R., Kuhar M. J. and Snyder S. H. (1978) Enkephalin and neurotensin: immunohistochemical localization and identification of an amygdalofugal pathway. Adv. Biochem. Psychopharmacol. 18, 7187.
  • Valdez G. R., Inoue K., Koob G. F., Rivier J., Vale W. and Zorrilla E. P. (2002a) Human urocortin II: mild locomotor suppressive and delayed anxiolytic-like effects of a novel corticotropin-releasing factor related peptide. Brain Res. 943, 142150.
  • Valdez G. R., Roberts A. J., Chan K., Davis H., Brennan M., Zorrilla E. P. and Koob G. F. (2002b) Increased ethanol self-administration and anxiety-like behavior during acute ethanol withdrawal and protracted abstinence: regulation by corticotropin-releasing factor. Alcohol. Clin. Exp. Res. 26, 14941501.
  • Valdez G. R., Zorrilla E. P., Rivier J., Vale W. W. and Koob G. F. (2003) Locomotor suppressive and anxiolytic-like effects of urocortin 3, a highly selective type 2 corticotropin-releasing factor agonist. Brain Res. 980, 206212.
  • Vaughan J., Donaldson C., Bittencourt J. et al (1995) Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor. Nature 378, 287292.
  • Veening J. G., Swanson L. W. and Sawchenko P. E. (1984) The organization of projections from the central nucleus of the amygdala to brainstem sites involved in central autonomic regulation: a combined retrograde transport-immunohistochemical study. Brain Res. 303, 337357.
  • Veinante P., Stoeckel M. E. and Freund-Mercier M. J. (1997) GABA- and peptide-immunoreactivities co-localize in the rat central extended amygdala. Neuroreport 8, 29852989.
  • Volpicelli J. R., Alterman A. I., Hayashida M. and O'Brien C. P. (1992) Naltrexone in the treatment of alcohol dependence. Arch. General Psychiatry 49, 876880.
  • Volpicelli J. R., Watson N. T., King A. C., Sherman C. E. and O'Brien C. P. (1995) Effect of naltrexone on alcohol ‘high’ in alcoholics. Am. J. Psychiatry 152, 613615.
  • De Waele J. P., Papachristou D. N. and Gianoulakis C. (1992) The alcohol-preferring C57BL/6 mice present an enhanced sensitivity of the hypothalamic beta-endorphin system to ethanol than the alcohol-avoiding DBA/2 mice. J. Pharmacol. Exp. Ther. 261, 788794.
  • De Waele J. P., Kiianmaa K. and Gianoulakis C. (1994) Spontaneous and ethanol-stimulated in vitro release of beta-endorphin by the hypothalamus of AA and ANA rats. Alcohol. Clin. Exp. Res. 18, 14681473.
  • Wagner C. K., Eaton M. J., Moore K. E. and Lookingland K. J. (1995) Efferent projections from the region of the medial zona incerta containing A13 dopaminergic neurons: a PHA-L anterograde tract-tracing study in the rat. Brain Res. 677, 229237.
  • Wallace D. M., Magnuson D. J. and Gray T. S. (1989) The amygdalo-brainstem pathway: selective innervation of dopaminergic, noradrenergic and adrenergic cells in the rat. Neurosci. Lett. 97, 252258.
  • Wallace D. M., Magnuson D. J. and Gray T. S. (1992) Organization of amygdaloid projections to brainstem dopaminergic, noradrenergic, and adrenergic cell groups in the rat. Brain Res. Bull. 28, 447454.
  • Weitemier A. Z., Woerner A., Backstrom P., Hyytia P. and Ryabinin A. E. (2001) Expression of c-Fos in Alko alcohol rats responding for ethanol in an operant paradigm. Alcohol. Clin. Exp. Res. 25, 704710.
  • Weninger S. C., Peters L. L. and Majzoub J. A. (2000) Urocortin expression in the Edinger-Westphal nucleus is up-regulated by stress and corticotropin-releasing hormone deficiency. Endocrinology 141, 256263.
  • Yoshimoto K., Ueda S., Kato B., Takeuchi Y., Kawai Y., Noritake K. and Yasuhara M. (2000) Alcohol enhances characteristic releases of dopamine and serotonin in the central nucleus of the amygdala. Neurochem. Int. 37, 369376.
  • Zhu G., Pollak L., Mottagui-Tabar S., Wahlestedt C., Taubman J., Virkkunen M., Goldman D. and Heilig M. (2003) NPY leu7pro and alcohol dependence in Finnish and Swedish Populations. Alcohol. Clin. Exp. Res. 27, 1924.
  • Zobel A. W., Nickel T., Kunzel H. E., Ackl N., Sonntag A., Ising M. and Holsboer F. (2000) Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression: the first 20 patients treated. J. Psychiatr. Res. 34, 171181.
  • World Health Organization (2001) A summary of global status report on alcohol. [wwwdocument]URL http://www.who.int/training/khow/publications/en/globalstatussummary.pdf [accessed23January2003]